[1] |
Peach CA, Carr AJ, Loughlin J. Recent advances in the genetic investigation of osteoarthritis[J]. Trends Mol Med, 2005, 11(4):186-191.
|
[2] |
Garstang SV, Stitik TP. Osteoarthritis: epidemiology, risk factors, and pathophysiology[J]. Am J Phy Med Rehabil, 2006, 85(11):S2-S11.
|
[3] |
Steinmeyer J. Cytokines in osteoarthritis-current status on the pharmacological intervention[J]. Front Biosci, 2004, 9(9):575-580.
|
[4] |
Loughlin J. The genetic epidemiology of human primary osteoarthritis: current status[J]. Expert Rev Mol Med, 2005, 7(9):1-12.
|
[5] |
Towne JB. IL-1F6,IL-1F8,and IL-1F9,signal throughIL-1RrD2 andIL-1RAcP to activatethel athway1eading to NF kappaB and MAP[J]. Eiol Cbem, 2014, 279(14):13677-13688.
|
[6] |
He W, Pelletier JP, Martel-Pelletier J, et al. Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines[J]. J Rheumatol, 2002, 29(3):546-553.
|
[7] |
Hajizadeh YS, Emami E, Nottagh M, et al. Effects of interleukin-1 receptor antagonist (IL-1Ra) gene 86 bp VNTR polymorphism on recurrent pregnancy loss: a case-control study[J]. Horm Mol Biol Clin Investig, 2017, 30(3):1868-1891.
|
[8] |
Kayar NA, Alptekin NÖ, Erdal ME. Interleukin-1 receptor antagonist gene polymorphism, adverse pregnancy outcome and periodontitis in Turkish women[J]. Arch Oral Biol, 2015, 60(12):1777-1783.
|
[9] |
Kristy LW, Jevseva DS. AAOS clinical practice guideline:surgical management of osteoarthritis of the knee[J]. J Am Acad Orthop Surg, 2016, 24(8):e94-e96.
|
[10] |
Bhattacharya R, Kumar V, Safawi E, et al. The knee skyline radiograph: its usefulness in the diagnosis of patello-femoral osteoarthritis[J]. Int Orthop, 2007, 31(2):247-252.
|
[11] |
Patel R, Dwivedi M, Mansuri MS, et al. Association of neuropeptide-Y (NPY) and interleukin-1beta (IL1B), genotype-phenotype correlation and plasma lipids with type-II diabetes[J/OL]. PLoS One, 2016, 11(10):e0164437.
URL
|
[12] |
Tabrez S, Jabir NR, Firoz CK, et al. Estimation of interleukin-1β promoter (-31 C/T and -511 T/C) polymorphisms and its level in coronary artery disease patients[J]. J Cell Biochem, 2017, 118(9):2977-2982.
|
[13] |
Szpecht D, Gadzinowski J, Nowak I, et al. The significance of IL-1β +3953C>T, IL-6 -174G>C and -596G>A, TNF-α -308G>A gene polymorphisms and 86 bp variable number tandem repeat polymorphism of IL-1RN in bronchopulmonary dysplasia in infants born before 32 weeks of gestation[J]. Cent Eur J Immunol, 2017, 42(3):287-293.
|
[14] |
Cai H, Sun HJ, Wang YH, et al. Relationships of common polymorphisms in IL-6, IL-1A, and IL-1B genes with susceptibility to osteoarthritis: a meta-analysis[J]. Clin Rheumatol, 2015, 34(8):1443-1453.
|
[15] |
Towne JE, Crka KE, Renshaw BR, et al. Interleukin(IL)-1F6,II-1F8,and IL-1F9,signal through IL-1RrD2 and IL-1RAcP to activatethel athway1eading to NF kappaB and MAPKs[J]. J Eiol Chem, 2004, 279(14):13677-13688.
|
[16] |
Smith AJ, Keen LJ, Billingham MJ, et al. Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis[J]. Genes Immun, 2004, 5(6):451-460.
|
[17] |
Leppävuori J, Kujala U, Kinnunen J, et al. Genome scan for predisposing loci for distal interphalangeal joint osteoarthritis: evidence for a locus on 2q[J]. Am J Hum Genet, 1999, 65(4):1060-1067.
|
[18] |
Forster T, Chapman K, Marcelline L, et al. Finer linkage mapping of primary osteoarthritis susceptibility loci on chromosomes 4 and 16 in families with affected women[J]. Arthritis Rheum, 2004, 50(1):98-102.
|
[19] |
Hamajima N, Matsuo K, Saito T, et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection[J]. Jpn J Cancer Res, 2001, 92(4):383-389.
|
[20] |
El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer[J]. Nature, 2000, 404(6776):398-402.
|
[21] |
Xu CF, Lewis K, Cantone KL, et al. Effectiveness of computational methods in haplotype prediction[J]. Hum Genet, 2002, 110(2):148-156.
|
[22] |
Meulenbelt I, Seymour AB, Nieuwland M, et al. Association of the interleukin-1 gene cluster with radiographic signs of osteoarthritis of the hip[J]. Arthritis Rheum, 2004, 50(4):1179-1186.
|
[23] |
Hall SK, Perregaux DG, Gabel CA, et al. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein[J]. Arthritis Rheum, 2004, 50(6):1976-1983.
|
[24] |
Moos V, Rudwaleit M, Herzog V, et al. Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis[J]. Arthritis Rheum, 2000, 43(11):2417-2422.
|
[25] |
Kanoh T, Hasegawa Y, Masui T, et al. Interleukin-1beta gene polymorphism associated with radiographic signs of osteoarthritis of the knee[J]. J Orthop Sci, 2008, 13(2):97-100.
|
[26] |
Colotta F, Dower Sk, Sims JE,et al The type II'decoy' receptor: a novel regulatory pathway for interleukin-1 [J].Immunol Tod,1994,15(12):562-566.
|
[27] |
Peat E, Thomas D, Duncan L, et al. Clinical classification criteria for knee 0steoarthritis:performance in the general population primary care[J]. Ann Rheum Dis, 2006, 65(4):1363-1367.
|
[28] |
Wang WZ, Guo X, Duan C, et al. Comparative analysis of gene expression profiles between the normal human cartilage and one with endemic osteoarthritis[J]. Osteoarthritis Cartilage, 2009, 17(6):83-89.
|
[29] |
Swellam M, Mahmoud MS, Samy N, et al. Potential influence of interleukin-1 receptor antagonist gene polymorphism on knee osteoarthritis risk[J]. Dis Markers, 2010, 28(5):299-305.
|
[30] |
王友成,刘铮,刘国华,等.TGF-β1基因C1348-T位点与膝骨关节炎的关系[J/CD].中华关节外科杂志(电子版),2015,9(4):500-504.
|